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Background/Aim. Coronary artery ectasia (CAE) is considered as a variant of atherosclerosis. Tumor necrosis factor-alpha (TNF-
α) and interleukin-6 (IL-6) are among the sensitive markers of systemic inﬂammation. The aim of this study was to evaluate the
plasmalevelsofthecytokines;TNF-αandIL-6inCAEpatients.Methods.PlasmaconcentrationsofTNF-αandIL-6weremeasured
in 36 patients with CAE (28 males, mean age: 58.2 ± 12 years), and results were compared with age and sex-matched controls
(n = 32)withoutcoronaryarteryectasia.TNF-αandIL-6concentrationsinbloodwereassesedbyenzyme-linkedimmunosorbent
assay (ELISA). Results. Baseline characteristics of the two groups were similar. TNF-α and IL-6 levels were signiﬁcantly higher in
CAE group than controls (15.6 ± 11.2pg/mL versus 7.8 ± 3.7pg/mL,P<. 001, and 17.2 ± 12.6v e r s u s7 .6 ± 2.1P<. 0001, resp.).
Conclusion. CAE patients showed increases in TNF-α and IL-6 levels compared to the controls. This study provides evidence for
alterations in the proinﬂamatory cytokines which suggest the involvement of the immune system in the pathophysiology of CAE.
Further placebo-controlled studies are needed to evaluate the clinical signiﬁcance of this increase in TNF-α and IL-6 levels.
Copyright © 2009 Mustafa Aydin et al. Thisis an open access articledistributed under theCreativeCommons AttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Coronary artery ectasia (CAE) has been deﬁned as localized
or diﬀuse dilation of the coronary arteries exceeding the 1.5
foldofnormaladjacentsegmentincoronaryangiography[1,
2]. CAE is a rare ﬁnding among coronary artery anomalies
and considered to be of either congenital or acquired origin
[2, 3]. Prevalence of CAE appears to rise in recent years [4].
It is estimated that 50% of CAE is related to atherosclerosis,
whereas 20%–30% of cases may be due to congenital
anomalies [3, 5].
Atherosclerosis is increasingly thought to be a chronic
inﬂammatory disease [5–7]. Although it has been suggested
that ectasia is commonly a variant of atherosclerosis, it
is not known clearly why some patients with obstructive
coronary artery disease (CAD) develop CAE, whereas others
do not [1–3]. Tumor necrosis factor-alpha (TNF-α)a n d
interleukin-6 (IL-6) are signiﬁcantly associated with coro-
nary atherosclerosis [8, 9]. Although the increase in the
plasma levels of TNF-α and IL-6 in obstructive CAD is well
known, limited data are available in CAE [10].
In this study, we aimed to evaluate the plasma levels of
the cytokines; TNF-α and IL-6 in CAE patients.
2. Method
2.1. Patients. The study was designed as a case-control
prospective study. The study population was selected from
a series of 1820 consecutive patients who underwent coro-
nary angiography in our hospital between January 2008
and September 2008 due to the presence of chest pain
or positive or equivocal results of noninvasive screening
tests for myocardial ischemia. Out of the 1820 patients,
36 consecutive patients who had angiographically normal
coronary arteries with CAE (group I, 28 male, mean age:
58.2 ± 12 years) and accepted to participate to our study
after giving informed consent were identiﬁed and compared
with age, and sex-matched 32 consecutive participants with
angiographically show normal coronary arteries without
CAE (group II, 25 male, mean age: 57.2 ± 10 years). No
signiﬁcant diﬀerence was present between the two groups
regarding the use of acetylsalicylic acid, beta blockers,
nitrates, calcium-channel blockers, and statins.2 Mediators of Inﬂammation
Written informed consent was obtained prior to enroll-
ment from all of the participants. The study protocol was
approved by the institutional ethics committee, and the
study was conducted in accordance with the Decleration
of Helsinki and Good Clinical practice (GCP)/International
Conference on Harmonization (ICH) guidelines.
Subjects were excluded if they had evidence of traumatic
injury, acute coronary syndrome history, obstructive CAD,
left ventricular dysfunction, left ventricular hypertrophy,
cardiomyopathies, congenital heart disease, valvular heart
disease, any abnormality in thyroid function test, arrhyth-
mias, clinically unstable medical illness such as hepatic or
renal impairment; a history of seizure, head trauma, or
stroke,activeinfection,allergy,activeinﬂammation,collagen
vascular disease, cancer, and any other primary disease
interfering with immune functions.
2.2. Coronary Angiograms and Immunoassay. In all patients,
coronary angiography was performed using the Philips
AngioscopX-ray(IntegrisBH5000,PhilipsMedicalSystems,
Best, The Netherlands) using standard Judkins technique.
Two experienced cardiologists, unaware of the patients
clinical characteristics and biochemical results, reviewed all
of the angiographic images. We used iohexol (Omnipaque,
Nycomed Ireland, Cork, Ireland) as contrast agent during
coronary angiography in the study patients.
A coronary diameter index was deﬁned for each segment
as the coronary diameter divided by the body surface area
(BSA). A coronary segment with a diameter index ≥1.5 fold
of the control group was deﬁned as ectatic. When there was
no identiﬁable adjacent normal segment, the mean diameter
of the corresponding coronary segment in the control group
served as normal values.
Bloodsamplesofallindividualsweretaken24hoursafter
coronary angiography from an antecubital vein. Blood sam-
ples were centrifuged immediately at 250g for 10 minutes
and stored at +4◦C until assay. Triglyceride, total cholesterol,
low-density lipoprotein (LDL) cholesterol, and high-density
lipoprotein cholesterol concentrations were measured by
automated chemistry analyzer (Aeroset, Abbott, Ill, USA) by
using commercially available kits.
Ten mL of heparinized venous blood were collected with
the plastic tubes from subjects at 08.00a.m. Blood samples
were santrifuged at 3000rpm (rotor diameter: 16cm) and
preserved at −80
◦C. Analyses were performed by the immu-
nologists, who were blinded to the condition of the samples.
IL-6, TNF-α enzyme-linked immunosorbent assay (ELISA)
kits were purchased by Biosource International Inc. (Camar-
illo, Calif, USA) and used according to the recommendations
ofthemanufacturer.TheminimumdetectabledosesofTNF-
α and IL-6 are 1.1pg/mL, 2.2pg/mL, respectively. There was
no cross-reactivity with other cytokines. All samples were
assayed in duplicate.
2.3. Statistical Analysis. Statistical analysis was performed by
using SPSS for windows 11.0 (Chicago, Ill, USA). Continu-
ous variables were expressed as mean ± SD, and categorical
v a r i a b l e sw e r ee x p r e s s e da sp e r c e n t a g e .C o m p a r i s o no f
categorical and continuous variables between groups was
performed by using x2 test and Student’s t-test or Mann-
Whitney U-test. The correlation between TNF-α and IL-
6 levels and the number of ectasic vessels was assessed
by the Pearson correlation, or the Spearman tests were
appropriate. A P-value of <.05 was considered statistically
signiﬁcant. Shapiro Wilks test was used for the assessment of
the distribution of continuous variables. All tests performed
were two tailed.
3. Results
Reproducibility was estimated by analyzing all recordings
on 2 separate occasions (intraobserver variability); to assess
interobserver variability, investigators were blinded. Intraob-
server and interobserver coeﬃcients of variation averaged
5%.
Baseline demographic, clinical, and angiographic char-
acteristics of the two groups were similar (Table 1). TNF-α
and IL-6 levels were signiﬁcantly higher in CAE group than
controls (15.6±11.2pg/mLversus 7.8±3.7pg/mL,P<. 001,
and 17.2 ± 12.6versus7.6 ± 2.1 P<. 0001, resp.) (Table 2).
Besides no correlation was found between the TNF-α,I L -
6 levels and the number of ectatic vessels (r = 0.012, and
r = 0.138, resp., P>. 05).
4. Discussion
The main ﬁnding of the present study was that patients
with isolated CAE had signiﬁcantly higher TNF-alfa and IL-
6 levels compared to control subjects with angiographically
normal coronary arteries.
CAE is a well-recognized angiographic ﬁnding of abnor-
mal coronary dilatation, and detected in 0.3%–5.3% of
consecutive angiographic studies [11]. The gold standard for
diagnosis of this type of ectasia is coronary angiography,
which provides information about the possible size, sample,
location, and number of ectasias. In fact, CAE is traditionally
consideredasavariantofcoronaryatherosclerosis.Clinically,
it predisposes to adverse coronary events like vasospasm,
thrombosis, and dissection [1]. In some studies, coronary
aneurysms have also been strongly associated with an
increased risk myocardial infarction [12]. Angina pectoris is
afrequentcomplaintofpatientswithisolatedCAE.Although
many etiologies of CAE have been reported, the common
coexistence with CAD has raised the idea that CAE may be a
variant of CAD. Individual case reports have shown that iso-
lated CAE may be a cause of silent myocardial ischemia [13].
In this study, we found signiﬁcantly higher levels of
IL-6 in CAE patients when compared to control subjects
with normal coronary arteries. Tokgozoglu et al. found
similar results with our ﬁndings [10]. We suggest that this
inﬂammatory state in the CAE patiens is responsible for
higher TNF-α and IL-6 levels in CAE.
Arecentlypublishedinvestigationreportedthatcoronary
ﬂow reserve is signiﬁcantly reduced in patients with CAE
and put forward that microvascular dysfunction may be the
underlying cause of exercise-induced myocardial ischemia
[14].Mediators of Inﬂammation 3
Table 1: Clinical and coronary angiographic characteristics of patients with isolated coronary artery ectasia and controls.
CAE (n = 36) Controls (n = 32) P
Age (mean±SD)(year)
(a) 58.2 ±12 57.2 ±10 >.05
Sex (male/female)
(a) 28/8 25/7 >.05
Systolic blood pressure (mmHg) 122 ±18 118 ±20 >.05
Diastolic blood pressure (mmHg) 74 ±87 5 ±9 >.05
Diabetes mellitus
(a) 21 26 >.05
Hypertension
(a) 18 13 >.05
Total cholesterol (mg/dL) 182 ±30 177 ±33 >.05
HDL-cholesterol (mg/dL 40 ±94 1 ±11 >.05
LDL-cholesterol (mg/dL) 106 ±8 105 ±7 >.05
Triglycerides (mg/dL) 125 ±35 119 ±37 >.05
Smoking
(a) 17 12 >.05
Family history
(a) 25 24 >.05
Aspirin
(a) 33 (92%) 28 (87%) >.05
Nitrate
(a) 16 (44%) 12 (38%) >.05
Beta blockers
(a) 28 (77%) 24 (75%) >.05
Angiographic ﬁndings of ectasias
Distribution of ectasia
LAD 20 (56%) — —
LCx 24 (66%) — —
RCA 15 (42%) — —
Number of involved vessels — —
One-vessel 14 (38%) — —
Two-vessel 17 (47%) — —
Three-vessel 4 (11%) — —
Number of ectasic segments (mean ± SD) (3.4 ±1.2) — —
CAE: coronary artery ectasia; LAD: left anterior descending artery; LCx: left circumﬂex artery; RCA: right coronary artery; (a)Chi square.
Table 2:TNF-αandIL-6levelsinthepatientswithCAEandcontrol
group.
CAE (n = 36) Controls (n = 32) P
TNF-α(pg/mL) 15.6 ±11.27 .8 ±3.7 <.001
IL-6(pg/mL) 17.2 ±12.67 .6 ±2.1 <.001
CAE: coronary artery ectasia, TNF-α tumor necrosis factor-alpha, IL-6; and
interleukin-6.
Inﬂammation is a protect mechanism of the body against
infectious agents and injury. There is now a well-known
common aggreement that atherosclerosis is an inﬂammatory
disorder of the vessels. Although cause and pathways of
atherosclerotic process are probably multiple and diﬀerent in
various clinical settings, the data showed that an inﬂamma-
tory process was involved in all stages of atherosclerosis [15]
including coronary spasm, delayed coronary ﬂow, coronary
microvessel dysfunction, silent myocardial ischemia, and
restenotic process [16, 17]. As a results of these data, the idea
of chronic inﬂammation as one of the key factors involved in
atherosclerosis has come out and broaden into a new area of
atherosclerotic diseases.
A few recent data have also emphasized that CAE is
associated with systemic inﬂammatory response exposed
by inreased inﬂammatory cytokines and C-reactive protein
(CRP). Recently, a study indicated a cytokine-induced tissue
inﬂammation in the pathogenesis of abdominal aortic
aneurysms, and it has been documented that circulating IL-
6 levels increase in these patients [18]. Tokgozoglu et al.
[10] studied with CAE, and found that serum IL-6 levels
were signiﬁcantly higher in patients with CAE compared
to controls. Our results conﬁrmed these results. We found
higher levels of IL-6 in CAE patients.
Yildirim et al. [19] studied the CAE and found that mean
ﬂuorescence intensity of CD45 and CD11b on the monocyte
surface of patients with CAE was signiﬁcantly higher when
compared to controls. They speculated that increased levels
of cellular adhesion molecules in patients with CAE may be
an indicator of endothelial activation and inﬂammation and
are likely to be in the causal pathway leading to coronary
artery ectasia. Turhan et al. [20] demonstrated that the levels
of CRP, a speciﬁc marker of chronic inﬂammation, were
signiﬁcantly higher in patients with isolated CAE. A recently
published study showed that patients with isolated CAE
have raised levels of plasma soluble intercellular adhesion
molecule-1 (ICAM-1), vascular cell adhesion molecule-1
(VCAM-1), and E-selectin in comparison with patients with
obstructive CAD without CAE and subjects with normal
coronary arteries [21]. In addition, Turhan et al. evaluated
CRP levels as a speciﬁc marker of inﬂammation in patients4 Mediators of Inﬂammation
with CAE. They showed that increased levels of CRP were
detected in patients with isolated CAE [22]. All these data
indicate the presence of a chronic inﬂammation in the
coronary circulation of the patients with CAE. Accordingly,
CAE has been suggested to be a destructive inﬂammatory
lesion of the vascular wall.
Brieﬂy, the approving of the importance of inﬂamma-
tion in atherosclerosis has both theoretical and practical
clinical implications. The data have demonstrated that
CAE is associated with inﬂammatory response exposed by
increased inﬂammatory cytokines. Such studies may clarify
the pathogenesis of CAE and direct towards new therapeutic
applications.
5. Conclusion
In conclusion, we found that TNF-α and IL-6 levels were
signiﬁcantly higher in CAE patients than subjects with
normal coronary arteries. We think that TNF-α and IL-
6 measurements may be a good prognostic value in CAE
patients as in stenotic ones, suggesting that vascular wall
inﬂammation may play a role in the pathogenesis of CAE.
Furtherplacebo-controlledstudiesareneededtoevaluatethe
clinical signiﬁcance of increases in these markers.
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